Related Experiment Video
Updated: Apr 4, 2026
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors
Maria Lluch-Senar1, Luca Cozzuto2, Jaime Cano1
1EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRG), Dr. Aiguader 88, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Dr. Aiguader 88, Barcelona, Spain.
Abstract:
The human respiratory tract pathogen M. pneumoniae is one of the best characterized minimal bacterium. Until now, two main groups of clinical isolates of this bacterium have been described (types 1 and 2), differing in the sequence of the P1 adhesin gene. Here, we have sequenced the genomes of 23 clinical isolates of M. pneumoniae. Studying SNPs, non-synonymous mutations, indels and genome rearrangements of these 23 strains and 4 previously sequenced ones, has revealed new subclasses in the two main groups, some of them being associated with the country of isolation. Integrative analysis of in vitro gene essentiality and mutation rates enabled the identification of several putative virulence factors and antigenic proteins; revealing recombination machinery, glycerol metabolism and peroxide production as possible factors in the genetics and physiology of these pathogenic strains. Additionally, the transcriptomes and proteomes of two representative strains, one from each of the two main groups, have been characterized to evaluate the impact of mutations on RNA and proteins levels. This study has revealed that type 2 strains show higher expression levels of CARDS toxin, a protein recently shown to be one of the major factors of inflammation. Thus, we propose that type 2 strains could be more toxigenic than type 1 strains of M. pneumoniae.
Insights
Genomic analysis of Mycoplasma pneumoniae reveals new subclasses within types 1 and 2, linked to geographic origin. Type 2 strains exhibit higher CARDS toxin expression, suggesting increased toxigenicity and inflammation potential.
Area of Science:
- Microbiology
- Genomics
- Pathogen Research
Background:
- Mycoplasma pneumoniae is a significant human respiratory pathogen.
- Clinical isolates were previously classified into two main types (1 and 2) based on P1 adhesin gene sequence.
Purpose of the Study:
- To perform whole-genome sequencing on 23 clinical M. pneumoniae isolates.
- To identify novel genetic variations, subclasses, and potential virulence factors.
- To compare transcriptomic and proteomic profiles of type 1 and type 2 strains.
Main Methods:
- Whole-genome sequencing of 23 clinical M. pneumoniae isolates.
- Analysis of single nucleotide polymorphisms (SNPs), mutations, indels, and genome rearrangements.
- Integrative analysis of in vitro gene essentiality and mutation rates.
- Transcriptome and proteome characterization of representative type 1 and type 2 strains.
Main Results:
- Discovery of new subclasses within M. pneumoniae types 1 and 2, some associated with country of isolation.
- Identification of recombination machinery, glycerol metabolism, and peroxide production as potential factors in pathogenesis.
- Type 2 strains demonstrated significantly higher expression levels of the CARDS toxin.
Conclusions:
- The genetic diversity of M. pneumoniae is greater than previously understood, with geographically linked subclasses.
- CARDS toxin expression is a key differentiator between M. pneumoniae types, with type 2 strains being potentially more virulent.
- Further research into virulence factors and host-inflammatory responses is warranted.
Related Concept Videos
01:14Atypical Pneumonia
01:29Modern Molecular Taxonomy
01:20Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...